Task B1: Phase I Clinical Trial to Evaluate a Therapeutic for Antibiotic Resistant Gram Negative and Positive Bacterial Infections

Dynport Vaccine Company, Llc, Frederick MD

Investigators

Abstract

The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.